Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Director | August 06, 2026 | August 14, 2026 |
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director | October 01, 2026 | October 03, 2026 |
| eHealth, Inc.EHTH · Entity 497 | Director | June 18, 2026 | June 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date August 06, 2026 · Filed August 14, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 143,234 |
Reported balance
After 2026-08-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-08-06 · Purchase · Acquired 20,000 · Balance 143,234 F1: The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 34,000 |
Reported balance
Holding disclosure · report date 2026-08-06 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance 34,000 F2: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST. |
Filing footnotes · ownership attribution and instrument terms
F1: The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
F2: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.
MOLINA HEALTHCARE, INC.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by Trust | 15,937 |
Reported balance
After 2026-10-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 304 · Balance 15,937 F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3: Represents the closing price of the Issuer's common stock on October 1, 2026. F4: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
F3: Represents the closing price of the Issuer's common stock on October 1, 2026.
F4: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.
eHealth, Inc.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 184,174 |
Reported balance
After 2026-06-18 transaction · row 1
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 61,041 · Balance 184,174 F1: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 62,932 |
Reported balance
Holding disclosure · report date 2026-06-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 62,932 F2: Shares held by the Dale B. Wolf Generation Skipping Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.
F2: Shares held by the Dale B. Wolf Generation Skipping Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2022 Filed Jul 1, 2022 23:39 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 194 | $282.90 | $54,882.60 |
DisclosureSEC source: 0001179929-22-000101 · wf-form4_165671873615887.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,824 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2022, the first day of the quarter, was $282.90, which resulted in a grant of 194 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2022. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:28 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 9,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-074331 · tm2219351-6_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,839 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:10 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 16,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-22-000076 · wf-form4_165550383811298.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,353 F1 · shares: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 00:59 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $33.02 Strike: $33.02 | $66,040.00 |
DisclosureSEC source: 0001179929-22-000086 · wf-form4_165464995891741.xml · derivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 2,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 00:59 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 2,000 | $33.02 | $66,040.00 |
DisclosureSEC source: 0001179929-22-000086 · wf-form4_165464995891741.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:36 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000070 · wf-form4_164911893944249.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,630 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 20:26 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 10,000 | $9.99 | $99,940.00 |
DisclosureSEC source: 0001333493-22-000034 · wf-form4_164737597430711.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 35,000 F3 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.96 to $10.00. F2 · ownership.nature: Shares held by the Dale B. Wolf Generation Skipping Trust. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:26 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 10,000 | $10.56 | $105,620.00 |
DisclosureSEC source: 0001333493-22-000034 · wf-form4_164737597430711.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 25,000 F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.475 to $10.60. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in footnotes (1) and (3) of this Form 4. F2 · ownership.nature: Shares held by the Dale B. Wolf Generation Skipping Trust. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:30 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000011 · wf-form4_164125619295690.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,468 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 01:31 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 15,000 | $22.53 | $337,935.00 |
DisclosureSEC source: 0001333493-21-000184 · wf-form4_163840863614256.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,000 F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.510 to $22.555. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the range set forth in this footnote. F2 · ownership.nature: Shares held by the Dale B. Wolf Generation Skipping Trust. Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 21:42 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 3,000 | $27.67 | $83,016.30 |
DisclosureSEC source: 0001333493-21-000179 · wf-form4_163701253515330.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,793 Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:42 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 24,000 | $29.97 | $719,258.40 |
DisclosureSEC source: 0001333493-21-000179 · wf-form4_163701253515330.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,793 F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.4392 to $30.4187. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the range set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 01:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 203 | $271.51 | $55,116.53 |
DisclosureSEC source: 0001179929-21-000157 · wf-form4_163339562476575.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,295 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2021, the first day of the quarter, was $271.51, which resulted in a grant of 203 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2021. Read SEC document |
| September 24, 2021 Filed Sep 28, 2021 01:52 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 2,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-21-000150 · wf-form4_163279392629950.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,793 F1 · shares: This represents an award of restricted stock units to the Company's chair of the board of directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested one year after the vesting commencement date of September 10, 2021, subject to the individual's continued service through such vesting date. In addition, the stock unit becomes 100% vested if the Company is subject to a change in control before the individual's service terminates. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:27 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 5,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-109347 · tm2124383-8_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,644 Read SEC document |
| August 23, 2021 Filed Sep 9, 2021 20:08 UTC Amendment | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 4,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-114192 · tm2124383-13_4aseq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,518 F1 · shares: This amendment is being filed to correct an inadvertent typographical error in the number of shares acquired by the reporting person in the reporting person's Form 4 filed on August 25, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $33.02 Strike: $33.02 | $82,550.00 |
DisclosureSEC source: 0001179929-21-000136 · wf-form4_162820757626830.xml · derivative · entry 3 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 2,500 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options are fully vested. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,500 | $277.19 | $692,975.00 |
DisclosureSEC source: 0001179929-21-000136 · wf-form4_162820757626830.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,092 F1 · price: Represents the selling price per share of all 2,500 shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 2,500 | $33.02 | $82,550.00 |
DisclosureSEC source: 0001179929-21-000136 · wf-form4_162820757626830.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:08 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 215 | $256.05 | $55,050.75 |
DisclosureSEC source: 0001179929-21-000123 · wf-form4_162526009831296.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,092 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2021, the first day of the quarter, was $256.05, which resulted in a grant of 215 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2021. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 23:49 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 3,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-21-000115 · wf-form4_162518333638170.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,385 F1 · shares: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 22:28 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $33.02 Strike: $33.02 | $82,550.00 |
DisclosureSEC source: 0001179929-21-000106 · wf-form4_162345050672175.xml · derivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 2,500 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 22:28 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 2,500 | $33.02 | $82,550.00 |
DisclosureSEC source: 0001179929-21-000106 · wf-form4_162345050672175.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2021 Filed May 12, 2022 20:44 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 7,000 | $24.78 | $173,473.30 |
DisclosureSEC source: 0001104659-22-059501 · tm2215132-1_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 14,000 F1 · shares: This Form 4 is being filed late due to inadvertent administrative error. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.66 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). F3 · ownership.nature: Securities held directly by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST. Read SEC document |
| April 01, 2021 Filed Apr 3, 2021 00:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 234 | $235.48 | $55,102.32 |
DisclosureSEC source: 0001179929-21-000071 · wf-form4_161740800476427.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,377 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2021, the first day of the quarter, was $235.48, which resulted in a grant of 234 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2021. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:16 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseClass A Common Stock | 7,000 | $37.99 | $265,952.40 |
DisclosureSEC source: 0001104659-21-038370 · tm214849d19_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,009 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.77 to $38.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| March 16, 2021 Filed Dec 30, 2021 21:22 UTC Amendment | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 7,000 | $37.95 | $265,661.20 |
DisclosureSEC source: 0001104659-21-154716 · tm2136543-1_4aseq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 7,000 F1 · shares: This amendment is being filed to include a purchase of shares of common stock of the issuer by the Dale B. Wolf Generation Skipping Trust (the "GST"), which was omitted inadvertently from the original filing. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.86 to $38.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). F3 · ownership.nature: Securities held directly by the GST. The reporting person is the investment manager of the GST. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 00:44 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 259 | $212.68 | $55,084.12 |
DisclosureSEC source: 0001179929-21-000009 · wf-form4_160980744268107.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,143 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2021 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2020, of $212.68. Thus, the grant this quarter for services as a Director is for 259 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2020. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:09 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 292 | $188.18 | $54,948.56 |
DisclosureSEC source: 0001179929-20-000126 · wf-form4_160167658238841.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,884 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2020 was $188.18, which resulted in a grant of 292 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2020. Read SEC document |
| September 09, 2020 Filed Sep 12, 2020 01:02 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 4,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-104529 · a4.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,009 Read SEC document |
| August 06, 2020 Filed Aug 7, 2020 23:16 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,000 | $194.32 | $777,278.00 |
DisclosureSEC source: 0001179929-20-000112 · wf-form4_159684207387328.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,592 F1 · price: Represents the weighted average of two sales on the Transaction Date (1,700 shares sold at $194.74118 and 2,300 shares sold at $194.00779). The Reporting Person undertakes to provide full information to the Commission upon request. Read SEC document |
| July 31, 2020 Filed Jul 31, 2020 21:20 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 2,000 | $71.06 | $142,110.00 |
DisclosureSEC source: 0001333493-20-000148 · wf-form4_159623042502396.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,164 F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.00 to $71.11. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:24 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 307 | $179.12 | $54,989.84 |
DisclosureSEC source: 0001179929-20-000098 · wf-form4_159373223510048.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,592 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2020 was $179.12, which resulted in a grant of 307 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2020. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 20:22 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 1,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-20-000108 · wf-form4_159190692643713.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,164 F1 · shares: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. Read SEC document |
| April 01, 2020 Filed Apr 4, 2020 00:30 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 419 | $131.16 | $54,956.04 |
DisclosureSEC source: 0001179929-20-000067 · wf-form4_158596019691385.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,285 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2020, the first day of the quarter, was $131.16, which resulted in a grant of 419 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 22:01 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseClass A Common Stock | 500 | $10.50 | $5,250.00 |
DisclosureSEC source: 0001104659-20-037406 · a4.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500 Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 23:56 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 405 | $135.69 | $54,954.45 |
DisclosureSEC source: 0001179929-20-000009 · wf-form4_157809578186659.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,866 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2020 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2019, of $135.69. Thus, the grant this quarter for services as a Director is for 405 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2019. Read SEC document |
| December 18, 2019 Filed Dec 21, 2019 02:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseClass A Common Stock | 10,000 | $10.20 | $102,000.00 |
DisclosureSEC source: 0001104659-19-075225 · a4.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $10.15 to $10.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-073992 · a4.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 22:22 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,500 | $135.51 | $474,270.30 |
DisclosureSEC source: 0001179929-19-000166 · wf-form4_157541174282850.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,461 F1 · price: Represents the actual selling price per share of all 3,500 shares. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 23:29 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 502 | $109.48 | $54,958.96 |
DisclosureSEC source: 0001179929-19-000154 · wf-form4_157005896205643.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,961 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2019, the first day of the quarter, was $109.48, which resulted in a grant of 502 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2019. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 21:05 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 1,000 | $82.10 | $82,100.00 |
DisclosureSEC source: 0001333493-19-000155 · wf-form4_156806311501877.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,533 Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 20:11 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 1,000 | $106.20 | $106,200.00 |
DisclosureSEC source: 0001333493-19-000131 · wf-form4_156641825013806.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,533 Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 20:11 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 1,000 | $103.90 | $103,895.00 |
DisclosureSEC source: 0001333493-19-000131 · wf-form4_156641825013806.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,533 Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 20:47 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 1,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-19-000112 · wf-form4_156512444790221.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,533 F1 · kind: This represents an initial award of restricted stock units. Each unit represents a contingent right to receive one share of the company's common stock upon vesting. The restricted stock units are scheduled to vest in four equal annual installments from the vesting commencement date of August 2, 2019, subject to the individual continuing to provide services to the company through the applicable vesting date. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:15 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 392 | $140.31 | $55,001.52 |
DisclosureSEC source: 0001179929-19-000125 · wf-form4_156219211258917.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,459 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2019, the first day of the quarter, was $140.31, which resulted in a grant of 392 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2019. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:26 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 380 | $144.70 | $54,986.00 |
DisclosureSEC source: 0001179929-19-000073 · wf-form4_155433397642207.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,067 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2019, the first day of the quarter, was $144.70, which resulted in a grant of 380 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2019. Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 00:35 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 473 | $116.22 | $54,972.06 |
DisclosureSEC source: 0001179929-19-000014 · wf-form4_154656209220001.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,687 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2019 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2018, of $116.22. Thus, the grant this quarter for services as a Director is for 473 shares of the Issuer's common stock. Read SEC document |
| November 09, 2018 Filed Nov 10, 2018 00:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,000 | $135.57 | $542,260.40 |
DisclosureSEC source: 0001179929-18-000192 · wf-form4_154180963687805.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,214 F1 · price: Represents the weighted average selling price per share with a selling price range between $135.4810 to $135.7300. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 23:56 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 371 | $148.14 | $54,959.94 |
DisclosureSEC source: 0001179929-18-000181 · wf-form4_153861097552954.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,214 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2018, the first day of the quarter, was $148.14, which resulted in a grant of 371 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.